Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
JAMA Dermatol 2020 Jun 03;[EPub Ahead of Print], JI Silverberg, EL Simpson, JP Thyssen, M Gooderham, G Chan, C Feeney, P Biswas, H Valdez, M DiBonaventura, C Nduaka, R RojoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.